Japanese Encephalitis (JE) is caused by a Flavivirus that, in a proportion of human cases, causes severe encephalitis leading to death or sometimes permanent disablement. It is a zoonotic disease, transferred from animals (commonly pigs or wild birds) by a mosquito vector to humans. In Southeast Asia it is thought to cause up to 50000 clinical cases and 10000 deaths per year. JE vaccination programme was carried out in high risk districts of Nepal. Japanese encephalitis vaccination was carried out during the years 2005, 2006, 2008 and 2009. The data collected from primary and secondary sources from the District Health Offices and other concerned central offices of the Department of Health Services, was tabulated and analysed. Thirty-five lakh of JE vaccine doses was procured by the Ministry of Health during the year 2006/2007. This vaccine was used in children under 15 years of age of 12 districts of JE risk and high-risk areas of Nepal. It was found that during the year 2005; 85% children in Banke and 81% in Kailali were vaccinated against JE. In Kailali and Banke districts it was found to be about 103% coverage in children population targeted, in Dang district it was 100% coverage, and in Bardiya district it was 73% coverege but in Rupandehi and Kanchanpur districts it was only about 40% and 41% respectively. JE vaccine coverage was very low in two Rupandehi and Kanchanpur districts during 2005 and 2006 and very high coverage during the year 2008. JE vaccination coverage results for the year 2009 have not been made available yet due to unavailability of data. This type of mass vaccination campaign needs regularlity, mass awareness and health education programme should be carried out before JE vaccination campaign in the children in the future.
N epal is one of the richest countries in the world in terms of bio-diversity due to its unique geographical position and altitudinal variation. The elevation of the country ranges from 60 m above sea level to the highest point on earth, Mr. Everest at 8,848 m, all within a distance of 150 km resulting into climatic conditions from Sub-tropical to Artic mentioned by Nepal Tourism Board, 2006. JE cases are observed mostly in Terai area 1 . In Southeast Asia it is thought to cause up to 50000 clinical cases and 10000 deaths per year 2 . The earlier reports have shown that the case fatality rate (CFR) is high in Nepal, and nationwide it has ranged from 15% to 46% for the years 1978 to 1994. Japanese Encephalitis (JE) has been occurring in the South-East Asia and Western Pacifi c Regions for a long time. In Nepal, it has occurred fi rst time in Rupandehi district then in Sunsari, Morang and latter in all 23 districts of tarai and inner tarai 1 . Incidence of this disease has been recorded fi rst time in different years in the following countries. Japan, China and Republic of Korea have reduced the incidence of this disease now 2 . These mosquitos can breed in sub-urban and periurban area provided the ecological condition similar to rural area are present 3, 4, 5 . In Nepal JE has been recorded and reported as a seasonal disease in Nepal. "Shrawan" (July and August) appears to have been the deadliest month for the Nepalese as far as human casualties from JE are concerned.
Infected Population and Deaths from Japanese Encephalitis (JE) Disease in Nepal (EDCD/DHS)
During the summer of 1983, 1152 people were immunized against Japanese Encephalitis at British Medical Hospital (BMH), Ghopa camp, Dharan Nepal 4 . This was the fi rst use of the Biken killed lyophilized vaccine in the British Army. Three doses of 1 ml. (0.5 ml for children under 3 years) given 10 days apart produced a protective neutralizing antibody response (titre more than 1:10) in almost 90% of people. Two doses of vaccine however seemed inadequate in that less than 40% of people sero-converted. Side effects were minimal and trivial. Studies of neutralizing antibodies before vaccination showed up to 30% of Nepalese people tested were already immune due to previous in apparent infection while all but one of the British Nationals' were fully susceptible. Kailali district is the most affected by the disease where vaccination campaign was started from July 2005 onwards according to the Districts Public Health Offi ce. Seven lakh twenty fi ve thousand three hundred ninety nine people have been targeted for vaccination programme for which 1229 vaccination centers were set up in Terai region for which 276 vaccination workers and 3700 volunteers were mobilized. It was conducted in; Kailali, Kanchanpur, Banke, Bardiya and Dang districts which were found to be most affected by encephalitis disease. 
What was done?

What was found?
JE risk six districts population of children between 1 to 15 age, sex and sex ration in Nepal is presented in Table 2 . Japanese Encephalitis (JE) Vaccination in Nepal during the year 2005 is presented in Table 3 Table  3 and Fig 2) . About 1.5 million people benefi ted from the Japanese Encephalitis (JE) vaccine in six different districts of the Terai region. These districts are Kanchanpur, Kailali, Banke, Bardiya, Dang and Rupandehi.
The JE vaccinated achievement results of children population from Udayapur, Bara and Rauthat districts have not been made available yet for the year 2009. On an average JE vaccination coverage was 96% during the year 2008 with the number of targeted children population. However over 100% coverage is seen in 4 districts out of 9 districts (See Table 5 and Fig 3) . 
JE Vaccinated Districts
The highest coverage in percentage of JE vaccination children population are 104% in Lalitpur, 103% in Bhaktapur, 102% in Mahottari and 101% in Chitwan, out of 9 districts with the targeted children population.
Number JE vaccination children targeted population versus with JE vaccinated achievement population is presented in Fig 4. 
What needs to be done?
The earlier reports have shown that the case fatality rate (CFR) is high in Nepal, and nationwide it has ranged from 15% to 46% for the years 1978 to 1994 6 . It has been proved that JE virus causes encephalitis in humans and abortion in pigs while no symptoms in other animals and birds. Mostly children aged fi ve to fi fteen is victimized than adults. About fi fty percent of the JE survivors are left with neurological syndrome and damage to the organs 1, 4, 5 .
The people in the districts are dying due to Japanese encephalitis, and it threatens to assume epidemic proportions. The government has just started its second round of vaccination under mass vaccination program for the disease, which should have been completed by 2006. Because of the delay in vaccination, the number of patients suffering from Japanese Encephalitis may increase and take an epidemic form.
The vaccine "anti JESA-14-14-2 live attenuated" is produced in China and that it was found to be above 98 percent effective in Chinese children 7 . In Nepal, some two million people live in the Tarai regions considered to be highly affected areas. In order to prevent the epidemic, more than three million doses of vaccines had been arranged during the year 2005. 
What has to be done?
For the reduction of JE cases in Nepal mass vaccination programme should be carried out every year for children in high risk districts of JE. Except symptomatic treatment there is no specifi c treatment for Japanese encephalitis. There are Japanese encephalitis vaccine prepared in Japan, China and USSR. There are two types of vaccines one liquid and other freeze dried. Vaccination can be done subcutaneously with two doses of 1 ml each above 3 years of age and 0.5 ml. for children upto 3 years of age at an interval of 7-14 days. Third doses should be given before one year. This will protect for 3 years in the endemic zone. One more booster dose after 3 years has been recommended which will give life long immunity to an individual 10 .
